Careium (CARE) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
11 Jul, 2025Executive summary
Q2 2025 was challenging, with net sales down 11.9% year-over-year to SEK 202.1 million, mainly due to financial lease accounting and lower product sales, but gross margin improved to 43.3% from 41.7%.
Operating profit (EBIT) fell to SEK 10.0 million (margin 4.9%) from SEK 21.8 million last year.
Cash flow from operations increased to SEK 20.2 million, with cash at period end SEK 34.1 million and net debt SEK 178.3 million.
Major breakthroughs included a first stationary alarm order in France and a five-year fully managed contract win in the UK.
Digital and web infrastructure was overhauled to support B2C growth, with momentum improving late in the quarter.
Financial highlights
Q2 net sales: SEK 202.1 million (down 11.9% year-over-year); service sales fell 9.4% to SEK 147.9 million; product sales dropped 18% to SEK 54.2 million.
Gross margin Q2: 43.3% (up from 41.7%); EBITDA: SEK 26.4 million (margin 13%); EBIT: SEK 10.0 million (margin 4.9%).
Q2 profit for the period: SEK 6.5 million (down 53.6%); Q2 EPS: SEK 0.23 (down 56.8%).
Cash flow from operations: SEK 20.2 million; free cash flow: SEK 1.0 million; cash at period end: SEK 34.1 million.
Net debt: SEK 178.3 million; leverage ratio: 1.3x; equity ratio: 64.7%.
Outlook and guidance
Guidance for 2025 is unchanged: net sales, profitability, and free cash flow before acquisitions expected to increase versus 2024.
Key drivers for H2 include a large contract in Norway starting in October and the Gloucestershire contract in the UK starting in Q3.
Negative impact from financial lease accounting in Sweden expected to decrease significantly from early 2026.
Management remains confident in the tender pipeline and win rates, especially in Sweden.
Focus remains on B2B, tendered opportunities, and M&A pipeline review.
Latest events from Careium
- Q4 2025 delivered modest sales growth, lower EBIT, and stronger cash flow amid margin pressure.CARE
Q4 202516 Feb 2026 - Aging demographics fuel growth in care tech, with innovation and recurring revenue driving strategy.CARE
ABGSC Investor Days12 Jan 2026 - Q3 2025 delivered 6% sales growth, higher margins, and strong product sales despite one-off costs.CARE
Q3 202524 Oct 2025 - Sales dropped 7.2%, but strong margins and new platforms support growth targets.CARE
Q3 202413 Jun 2025 - Q2 sales and EBIT surged, driven by EU market gains despite UK/Nordic delays.CARE
Q2 202413 Jun 2025 - Gross margin rose to 44.5% despite lower sales, with growth outside Sweden and strong 2025 outlook.CARE
Q1 20255 Jun 2025 - Strong sales and profit growth, with 2025 set for further expansion and innovation.CARE
Q4 20245 Jun 2025